{
  "clinical_study": {
    "title": "Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)",
    "nct_identifier": "NCT05557942",
    "indication": "Pulmonary Arterial Hypertension",
    "intervention": "AV-101",
    "study_arms": {
      "intervention": 6,
      "placebo": 0
    },
    "number_of_participants": 186,
    "average_age": null,
    "age_range": [
      "18 Years",
      "75 Years"
    ],
    "interventional_drug": [
      {
        "name": "AV-101",
        "dose": null,
        "frequency": null,
        "formulation": "dry powder inhalation"
      }
    ],
    "endpoints": [
      "Number of Participants With Treatment-emergent Adverse Events"
    ],
    "baseline_characteristics": [
      "Age, Continuous",
      "Age, Continuous",
      "Age, Continuous",
      "Age, Continuous",
      "Age, Continuous",
      "Age, Continuous",
      "Age, Continuous",
      "Sex: Female, Male - Female",
      "Sex: Female, Male - Female",
      "Sex: Female, Male - Female",
      "Sex: Female, Male - Female",
      "Sex: Female, Male - Female",
      "Sex: Female, Male - Female",
      "Sex: Female, Male - Female",
      "Sex: Female, Male - Male",
      "Sex: Female, Male - Male",
      "Sex: Female, Male - Male",
      "Sex: Female, Male - Male",
      "Sex: Female, Male - Male",
      "Sex: Female, Male - Male",
      "Sex: Female, Male - Male",
      "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "Race (NIH/OMB) - American Indian or Alaska Native",
      "Race (NIH/OMB) - American Indian or Alaska Native",
      "Race (NIH/OMB) - American Indian or Alaska Native",
      "Race (NIH/OMB) - American Indian or Alaska Native",
      "Race (NIH/OMB) - American Indian or Alaska Native",
      "Race (NIH/OMB) - American Indian or Alaska Native",
      "Race (NIH/OMB) - American Indian or Alaska Native",
      "Race (NIH/OMB) - Asian",
      "Race (NIH/OMB) - Asian",
      "Race (NIH/OMB) - Asian",
      "Race (NIH/OMB) - Asian",
      "Race (NIH/OMB) - Asian",
      "Race (NIH/OMB) - Asian",
      "Race (NIH/OMB) - Asian",
      "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "Race (NIH/OMB) - Black or African American",
      "Race (NIH/OMB) - Black or African American",
      "Race (NIH/OMB) - Black or African American",
      "Race (NIH/OMB) - Black or African American",
      "Race (NIH/OMB) - Black or African American",
      "Race (NIH/OMB) - Black or African American",
      "Race (NIH/OMB) - Black or African American",
      "Race (NIH/OMB) - White",
      "Race (NIH/OMB) - White",
      "Race (NIH/OMB) - White",
      "Race (NIH/OMB) - White",
      "Race (NIH/OMB) - White",
      "Race (NIH/OMB) - White",
      "Race (NIH/OMB) - White",
      "Race (NIH/OMB) - More than one race",
      "Race (NIH/OMB) - More than one race",
      "Race (NIH/OMB) - More than one race",
      "Race (NIH/OMB) - More than one race",
      "Race (NIH/OMB) - More than one race",
      "Race (NIH/OMB) - More than one race",
      "Race (NIH/OMB) - More than one race",
      "Race (NIH/OMB) - Unknown or Not Reported",
      "Race (NIH/OMB) - Unknown or Not Reported",
      "Race (NIH/OMB) - Unknown or Not Reported",
      "Race (NIH/OMB) - Unknown or Not Reported",
      "Race (NIH/OMB) - Unknown or Not Reported",
      "Race (NIH/OMB) - Unknown or Not Reported",
      "Race (NIH/OMB) - Unknown or Not Reported"
    ]
  },
  "endpoints": [
    {
      "name": "Number of Participants With Treatment-emergent Adverse Events",
      "description": "An Adverse Event (AE) was defined as any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Serious Adverse Events (SAEs) were defined as death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect, or an important medical event that jeopardized participant and required medical intervention to prevent 1 of the outcomes listed in this definition. A summary of other non-serious AEs and all serious AEs, regardless of causality is located in Reported AE section.",
      "timepoint": "From date of first dose to 30 days after date of last dose (up to approximately 21 months)",
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "9",
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": ""
    },
    {
      "name": "Number of Participants With Treatment-emergent Adverse Events",
      "description": "An Adverse Event (AE) was defined as any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Serious Adverse Events (SAEs) were defined as death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect, or an important medical event that jeopardized participant and required medical intervention to prevent 1 of the outcomes listed in this definition. A summary of other non-serious AEs and all serious AEs, regardless of causality is located in Reported AE section.",
      "timepoint": "From date of first dose to 30 days after date of last dose (up to approximately 21 months)",
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "11",
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": ""
    },
    {
      "name": "Number of Participants With Treatment-emergent Adverse Events",
      "description": "An Adverse Event (AE) was defined as any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Serious Adverse Events (SAEs) were defined as death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect, or an important medical event that jeopardized participant and required medical intervention to prevent 1 of the outcomes listed in this definition. A summary of other non-serious AEs and all serious AEs, regardless of causality is located in Reported AE section.",
      "timepoint": "From date of first dose to 30 days after date of last dose (up to approximately 21 months)",
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "12",
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": ""
    },
    {
      "name": "Number of Participants With Treatment-emergent Adverse Events",
      "description": "An Adverse Event (AE) was defined as any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Serious Adverse Events (SAEs) were defined as death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect, or an important medical event that jeopardized participant and required medical intervention to prevent 1 of the outcomes listed in this definition. A summary of other non-serious AEs and all serious AEs, regardless of causality is located in Reported AE section.",
      "timepoint": "From date of first dose to 30 days after date of last dose (up to approximately 21 months)",
      "arm": "Continuing AV-101 10 mg",
      "average_value": "26",
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": ""
    },
    {
      "name": "Number of Participants With Treatment-emergent Adverse Events",
      "description": "An Adverse Event (AE) was defined as any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Serious Adverse Events (SAEs) were defined as death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect, or an important medical event that jeopardized participant and required medical intervention to prevent 1 of the outcomes listed in this definition. A summary of other non-serious AEs and all serious AEs, regardless of causality is located in Reported AE section.",
      "timepoint": "From date of first dose to 30 days after date of last dose (up to approximately 21 months)",
      "arm": "Continuing AV-101 35 mg",
      "average_value": "25",
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": ""
    },
    {
      "name": "Number of Participants With Treatment-emergent Adverse Events",
      "description": "An Adverse Event (AE) was defined as any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Serious Adverse Events (SAEs) were defined as death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect, or an important medical event that jeopardized participant and required medical intervention to prevent 1 of the outcomes listed in this definition. A summary of other non-serious AEs and all serious AEs, regardless of causality is located in Reported AE section.",
      "timepoint": "From date of first dose to 30 days after date of last dose (up to approximately 21 months)",
      "arm": "Continuing AV-101 70 mg",
      "average_value": "21",
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": ""
    }
  ],
  "baseline_measures": [
    {
      "name": "Age, Continuous",
      "description": "Age, Continuous",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "49.1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "years"
    },
    {
      "name": "Age, Continuous",
      "description": "Age, Continuous",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "45.9",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "years"
    },
    {
      "name": "Age, Continuous",
      "description": "Age, Continuous",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "47.9",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "years"
    },
    {
      "name": "Age, Continuous",
      "description": "Age, Continuous",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "45.5",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "years"
    },
    {
      "name": "Age, Continuous",
      "description": "Age, Continuous",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "47.4",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "years"
    },
    {
      "name": "Age, Continuous",
      "description": "Age, Continuous",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "46.4",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "years"
    },
    {
      "name": "Age, Continuous",
      "description": "Age, Continuous",
      "timepoint": null,
      "arm": "Total",
      "average_value": "46.8",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "years"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Female",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "15",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Female",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "15",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Female",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "13",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Female",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "34",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Female",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "38",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Female",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "35",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Female",
      "timepoint": null,
      "arm": "Total",
      "average_value": "150",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Male",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Male",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Male",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Male",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "11",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Male",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "10",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Male",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "6",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Sex: Female, Male",
      "description": "Sex: Female, Male - Male",
      "timepoint": null,
      "arm": "Total",
      "average_value": "36",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "8",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "10",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "12",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Hispanic or Latino",
      "timepoint": null,
      "arm": "Total",
      "average_value": "39",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "14",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "14",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "12",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "31",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "34",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "27",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Not Hispanic or Latino",
      "timepoint": null,
      "arm": "Total",
      "average_value": "132",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "6",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "4",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "2",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Ethnicity (NIH/OMB)",
      "description": "Ethnicity (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Total",
      "average_value": "15",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - American Indian or Alaska Native",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - American Indian or Alaska Native",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - American Indian or Alaska Native",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - American Indian or Alaska Native",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - American Indian or Alaska Native",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - American Indian or Alaska Native",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "2",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - American Indian or Alaska Native",
      "timepoint": null,
      "arm": "Total",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Asian",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "2",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Asian",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "8",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Asian",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Asian",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "11",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Asian",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "12",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Asian",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "9",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Asian",
      "timepoint": null,
      "arm": "Total",
      "average_value": "45",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Native Hawaiian or Other Pacific Islander",
      "timepoint": null,
      "arm": "Total",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Black or African American",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Black or African American",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Black or African American",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Black or African American",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "2",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Black or African American",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Black or African American",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Black or African American",
      "timepoint": null,
      "arm": "Total",
      "average_value": "8",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - White",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "15",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - White",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "8",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - White",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "11",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - White",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "27",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - White",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "31",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - White",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "24",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - White",
      "timepoint": null,
      "arm": "Total",
      "average_value": "116",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - More than one race",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - More than one race",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - More than one race",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - More than one race",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - More than one race",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - More than one race",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - More than one race",
      "timepoint": null,
      "arm": "Total",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 10 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 35 mg",
      "average_value": "1",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Placebo Crossover AV-101 70 mg",
      "average_value": "0",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Continuing AV-101 10 mg",
      "average_value": "5",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Continuing AV-101 35 mg",
      "average_value": "4",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Continuing AV-101 70 mg",
      "average_value": "3",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    },
    {
      "name": "Race (NIH/OMB)",
      "description": "Race (NIH/OMB) - Unknown or Not Reported",
      "timepoint": null,
      "arm": "Total",
      "average_value": "13",
      "lower_end": null,
      "upper_end": null,
      "statistical_significance": null,
      "units": "Participants"
    }
  ]
}